{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:24:47Z","timestamp":1761899087785,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.cancergen.2020.02.006","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T02:25:42Z","timestamp":1583461542000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Novel and recurrent germline mutations in the VHL gene in 5 Arab patients with Von Hippel-Lindau disease"],"prefix":"10.1016","volume":"243","author":[{"given":"Muhammad","family":"Faiyaz-Ul-Haque","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masood","family":"Jamil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halah","family":"Abalkhail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fouad","family":"Al-Dayel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sulman","family":"Basit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zafar","family":"Nawaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed H.E.","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2020.02.006_bib0001","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ejhg.2010.175","article-title":"von Hippel-Lindau disease: a clinical and scientific review","volume":"19","author":"Maher","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0002","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/jmg.28.7.443","article-title":"Von Hippel-Lindau disease: a genetic study","volume":"28","author":"Maher","year":"1991","journal-title":"J Med Genet"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0003","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajmg.a.33139","article-title":"Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service","volume":"152A","author":"Evans","year":"2010","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0004","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0005","doi-asserted-by":"crossref","first-page":"11032","DOI":"10.1074\/jbc.M208681200","article-title":"Multiple splice variants of the human HIF-3 alpha locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex","volume":"278","author":"Maynard","year":"2003","journal-title":"J Biol Chem."},{"key":"10.1016\/j.cancergen.2020.02.006_bib0006","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1038\/onc.2009.12","article-title":"VHL type 2B gene mutation moderates HIF dosage in vitro and in vivo","volume":"28","author":"Lee","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0007","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10689-010-9357-2","article-title":"Clinical and molecular characterization of Brazilian families with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation","volume":"9","author":"Gomy","year":"2010","journal-title":"Fam Cancer"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0008","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1136\/jmg.40.3.e31","article-title":"High frequency of novel germline mutations in the VHL gene in the heterogeneous population of Brazil","volume":"40","author":"Rocha","year":"2003","journal-title":"J Med Genet"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0009","doi-asserted-by":"crossref","first-page":"38456","DOI":"10.18632\/oncotarget.16594","article-title":"Genotype-phenotype correlations in Chinese von Hippel-Lindau disease patients","volume":"8","author":"Peng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0010","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/(SICI)1098-1004(1998)12:6<424::AID-HUMU9>3.0.CO;2-H","article-title":"Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma","volume":"12","author":"Olschwang","year":"1998","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0011","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10689-017-0058-y","article-title":"Genotype phenotype correlation in Asian Indian von Hippel-Lindau (VHL) syndrome patients with pheochromocytoma\/paraganglioma","volume":"17","author":"Lomte","year":"2018","journal-title":"Fam Cancer"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0012","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1349-7006.1996.tb00240.x","article-title":"Molecular genetic diagnosis of von Hippel-Lindau disease: analysis of five Japanese families","volume":"87","author":"Kanno","year":"1996","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0013","first-page":"521","article-title":"Genetic analysis of von Hippel-Lindau disease","volume":"31","author":"Nordstrom-O'Brien","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0014","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.1136\/jmg.39.7.e38","article-title":"Germline mutations in the von Hippel-Lindau (VHL) gene in patients from Poland: disease presentation in patients with deletions of the entire VHL gene","volume":"39","author":"Cybulski","year":"2002","journal-title":"J Med Genet"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0015","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00218913","article-title":"Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours","volume":"93","author":"Crossey","year":"1994","journal-title":"Hum Genet"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0016","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/humu.20385","article-title":"Genotype-phenotype correlations in von Hippel-Lindau disease","volume":"28","author":"Ong","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0017","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/jmg.33.4.328","article-title":"Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations","volume":"33","author":"Maher","year":"1996","journal-title":"J Med Genet"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0018","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1399-0004.2007.00827.x","article-title":"Frequency of von Hippel-Lindau germline mutations in classic and non-classic von Hippel-Lindau disease identified by dna sequencing, southern blot analysis and multiplex ligation-dependent probe amplification","volume":"72","author":"Hes","year":"2007","journal-title":"Clin Genet"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0019","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1086\/302726","article-title":"Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents","volume":"66","author":"Sgambati","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0020","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K","article-title":"Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene","volume":"12","author":"Stolle","year":"1998","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0021","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/jnnp.67.6.758","article-title":"The impact of molecular genetic analysis of the vhl gene in patients with haemangioblastomas of the central nervous system","volume":"67","author":"Gl\u00e4sker","year":"1999","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0022","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1159\/000080467","article-title":"A novel germline mutation in the von Hippel-Lindau gene in patients in Kuwait","volume":"13","author":"Alfadhli","year":"2004","journal-title":"Med Princ Pract"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0023","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1469-1809.2011.00647.x","article-title":"Identification and in silico analysis of novel von Hippel-Lindau (VHL) gene variants from a large population","volume":"75","author":"Leonardi","year":"2011","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0024","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/(SICI)1097-0215(19980729)77:3<337::AID-IJC5>3.0.CO;2-P","article-title":"Germline mutations in the vhl gene in patients presenting with phaeochromocytomas","volume":"77","author":"van der Harst","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0025","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ng.2891","article-title":"Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing","volume":"46","author":"Gerlinger","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0026","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/humu.1380050109","article-title":"Germline mutations in the von hippel-lindau disease tumor suppressor gene: correlations with phenotype","volume":"5","author":"Chen","year":"1995","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0027","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/gcc.22116","article-title":"Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma","volume":"53","author":"Gossage","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0028","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1093\/hmg\/3.12.2169","article-title":"Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma","volume":"3","author":"Foster","year":"1994","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0029","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1038\/sj.onc.1204692","article-title":"VHL gene alterations in renal cell carcinoma patients: novel hotspot or founder mutations and linkage disequilibrium","volume":"20","author":"Ma","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2407-5-57","article-title":"Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from the Netherlands cohort study","volume":"5","author":"van Houwelingen","year":"2005","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0031","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.eururo.2012.09.005","article-title":"Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma","volume":"63","author":"Hakimi","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0032","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/ijc.28768","article-title":"Multilayer-omics analysis of renal cell carcinoma, including the whole exome, methylome and transcriptome","volume":"135","author":"Arai","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0033","doi-asserted-by":"crossref","first-page":"31128","DOI":"10.1038\/srep31128","article-title":"VHLdb: a database of von Hippel-Lindau protein interactors and mutations","volume":"6","author":"Tabaro","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0034","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/hmg\/3.8.1303","article-title":"Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype","volume":"3","author":"Crossey","year":"1994","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0035","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc885","article-title":"Molecular basis of the VHL hereditary cancer syndrome","volume":"2","author":"Kaelin","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0036","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/hmg\/10.10.1019","article-title":"von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF","volume":"10","author":"Hoffman","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0037","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/onc.2017.338","article-title":"The HIF and other quandaries in VHL disease","volume":"37","author":"Tarade","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0038","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/prot.22419","article-title":"Structural bioinformatics mutation analysis reveals genotype-phenotype correlations in von Hippel-Lindau disease and suggests molecular mechanisms of tumorigenesis","volume":"77","author":"Forman","year":"2009","journal-title":"Proteins"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0039","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1210\/jc.2014-1732","article-title":"Von Hippel-Lindau disease associated pulmonary carcinoid with cranial metastasis","volume":"99","author":"Zhang","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergen.2020.02.006_bib0040","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.athoracsur.2013.11.080","article-title":"Multiple lung adenocarcinomas associated with von Hippel-Lindau disease","volume":"98","author":"Ikeda","year":"2014","journal-title":"Ann Thorac Surg"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776220301460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776220301460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:43:44Z","timestamp":1761896624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776220301460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":40,"alternative-id":["S2210776220301460"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2020.02.006","relation":{},"ISSN":["2210-7762"],"issn-type":[{"type":"print","value":"2210-7762"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel and recurrent germline mutations in the VHL gene in 5 Arab patients with Von Hippel-Lindau disease","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2020.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}